These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17849796)

  • 21. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD; Strucchi C; Luisi M; Casarosa E; Lanzoni C; Baraldi E; Ricchieri F; Mehmeti H; Genazzani AR
    Gynecol Endocrinol; 2006 Jan; 22(1):36-43. PubMed ID: 16522532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of metformin in correcting hyperinsulinemia, menstrual irregularity and anovulation in polycystic ovary syndrome.
    Zafar S
    J Ayub Med Coll Abbottabad; 2005; 17(4):54-6. PubMed ID: 16599037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.
    Elnashar A; Fahmy M; Mansour A; Ibrahim K
    Fertil Steril; 2007 Aug; 88(2):406-9. PubMed ID: 17335818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW; Kilpatrick ES; Keevil BG; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):233-7. PubMed ID: 18547343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of metformin on insulin resistance and on ovarian steroidogenesis in women with polycystic ovary syndrome].
    De Conciliis B; Passannanti G; Romano L; Santarpia R
    Minerva Ginecol; 2001 Aug; 53(4):239-50. PubMed ID: 11431640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metformin therapy in patients with polycystic ovarian syndrome.
    Hasan JA; Memon GU
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):712-5. PubMed ID: 16300709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome.
    Palomba S; Falbo A; Orio F; Tolino A; Zullo F
    Fertil Steril; 2009 Jun; 91(6):2557-67. PubMed ID: 18440534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does metformin augment the ovulation inducing effects of clomiphene in non-obese women with polycystic ovary syndrome?
    Chaudhury K; Chaudhury S; Chowdhury S
    J Indian Med Assoc; 2008 Oct; 106(10):643-4, 646-8. PubMed ID: 19552097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome.
    Glueck CJ; Aregawi D; Agloria M; Winiarska M; Sieve L; Wang P
    Metabolism; 2006 Dec; 55(12):1582-9. PubMed ID: 17142128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.
    Nawrocka J; Starczewski A
    Gynecol Endocrinol; 2007 Apr; 23(4):231-7. PubMed ID: 17505944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
    Fleming R; Harborne L; MacLaughlin DT; Ling D; Norman J; Sattar N; Seifer DB
    Fertil Steril; 2005 Jan; 83(1):130-6. PubMed ID: 15652898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin treatment is effective in obese teenage girls with PCOS.
    De Leo V; Musacchio MC; Morgante G; Piomboni P; Petraglia F
    Hum Reprod; 2006 Sep; 21(9):2252-6. PubMed ID: 16785260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased insulin sensitivity by metformin enhances intense-pulsed-light-assisted hair removal in patients with polycystic ovary syndrome.
    Rezvanian H; Adibi N; Siavash M; Kachuei A; Shojaee-Moradie F; Asilian A
    Dermatology; 2009; 218(3):231-6. PubMed ID: 19092235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome.
    Ertunc D; Tok EC; Aktas A; Erdal EM; Dilek S
    Hum Reprod; 2005 May; 20(5):1207-12. PubMed ID: 15665022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
    Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference.
    Bruno RV; de Avila MA; Neves FB; Nardi AE; Crespo CM; Sobrinho AT
    Fertil Steril; 2007 Aug; 88(2):510-2. PubMed ID: 17433315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
    Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D
    Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.